Q3 2019 Holdings
Filed 2019-11-14 | 89 holdings | $36.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atricure Inc(ATRC) | COM | 04963C209 | $7.9M | 318,729 | 21.7% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $5.8M | 60,480 | 15.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $4.8M | 418,727 | 13.0% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $3.2M | 828,038 | 8.9% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $2.7M | 580,524 | 7.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $2.5M | 21,969 | 6.8% |
| Alector Inc(ALEC) | COM | 014442107 | $2.1M | 145,000 | 5.7% |
| Accuray Inc(ARAY) | COM | 004397105 | $1.9M | 674,300 | 5.1% |
| Arcturus Therapeutics Hldg I(ARCT) | COM | 03969T109 | $1.8M | 173,914 | 4.9% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $1.4M | 483,388 | 3.8% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $1.2M | 100,000 | 3.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $738.0K | 100,000 | 2.0% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $264.0K | 50,000 | 0.7% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $48.0K | 13,680,554 | 0.1% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $17.5K | 124,806 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $12.0K | 636,013 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $9.1K | 123,218 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $8.0K | 52,509 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $7.3K | 470,000 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $6.9K | 378,924 | 0.0% |
| Ishares TR Nasdaq Biotech(IBB) | ETF | 464287556 | $6.5K | 64,900 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $5.8K | 64,508 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $5.7K | 142,764 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $5.5K | 287,748 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.4K | 36,338 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $4.3K | 93,942 | 0.0% |
| Luminex Corp | COM | 55027E102 | $4.2K | 204,091 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $4.1K | 169,800 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $4.1K | 197,554 | 0.0% |
| Biohaven Pharmaceuticals Hold(BHVN) | COM | G11196105 | $4.0K | 95,000 | 0.0% |
| Menlo Therapeutics Inc | COM | 586858102 | $3.8K | 856,936 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $3.8K | 530,262 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $3.7K | $4,000,000 | 0.0% |
| Translate BIO Inc | COM | 89374L104 | $3.6K | 364,229 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.0K | 330,667 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $2.6K | 200,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $2.3K | 25,500 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COM | 48283N106 | $2.2K | 886,177 | 0.0% |
| Cardiovascular Systems Inc(CSIIEUR) | COM | 141619106 | $2.2K | 46,200 | 0.0% |
| Biotelemetry Inc(BEATEUR) | COM | 090672106 | $1.8K | 45,300 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $1.8K | 21,210 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $1.8K | 349,996 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $1.8K | 47,308 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $1.7K | 118,314 | 0.0% |
| Eloxx Pharmaceuticals Inc | COM | 29014R103 | $1.7K | 375,000 | 0.0% |
| Achillion Pharmaceuticals(ACHNEUR) | COM | 00448Q201 | $1.6K | 438,884 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | COM NEW | 372427401 | $1.6K | 542,564 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.6K | 103,658 | 0.0% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $1.5K | 261,521 | 0.0% |
| Phasebio Pharmaceuticals Inc | COM | 717224109 | $1.5K | 360,542 | 0.0% |